Benedict Susan L, Ni Oliver K, Schloesser Peter, White Keith S, Bale James F
Department of Pediatrics, University of Utah, Primary Children's Medical Center, Salt Lake City, Utah 84158, USA.
J Child Neurol. 2007 Feb;22(2):225-7. doi: 10.1177/0883073807300296.
Recombinant tissue plasminogen activator, although the standard of care for the management of acute ischemic stroke in adults, is used infrequently in children. The authors describe the use of intra-arterial recombinant tissue plasminogen activator in a young child with embolic stroke. Thrombolysis restored flow to the affected middle cerebral artery and appeared to limit the extent of the infarction and the severity of the subsequent neurologic deficits.
重组组织型纤溶酶原激活剂虽然是成人急性缺血性卒中治疗的标准疗法,但在儿童中很少使用。作者描述了在一名患有栓塞性卒中的幼儿中使用动脉内重组组织型纤溶酶原激活剂的情况。溶栓恢复了受影响的大脑中动脉的血流,似乎限制了梗死范围和随后神经功能缺损的严重程度。